Avalo Therapeutics, Inc. 4 filing

Filed 2026-03-31 · Report date 2026-03-28 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001789335-26-000004
Form type: 4
CIK: 0001534120
Primary document: https://www.sec.gov/Archives/edgar/data/1534120/000178933526000004/xslF345X06/form4-03312026_080349.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Avalo Therapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change